St Jude gets US nod for software upgrade for ICD remote monitor
This article was originally published in Clinica
Executive Summary
The US FDA has given St Jude Medical the all-clear to sell a new version of its remote monitoring system for patients implanted with certain of its implantable cardioverter defibrillators (ICDs). The Housecall Plus 2.1 software upgrade enables medical professionals to create electronic PDF files of a patient's device interrogation results and either transmit them electronically or post them on a secure web site for further review by physicians. Remote monitoring simplifies follow-up visits for patients and can reduce costs associated with unnecessary office and emergency room visits. With the number of ICD patients expected to expand significantly over the next few years, physicians face an enormous challenge in managing regular follow-up visits for those patients, said the St Paul, Minnesota firm.
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.